Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (20)
Early P 1 (2)
P 2 (3)
P 3 (1)
P 4 (1)

Trial Status

Completed14
Recruiting9
Not Yet Recruiting4
Unknown2
Active Not Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT04055428Phase 2Recruiting

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

NCT02745613Not ApplicableCompletedPrimary

Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity

NCT07675499Phase 2Recruiting

Exercise and Intranasal Insulin in Type 2 Diabetes

NCT06138821Not ApplicableRecruiting

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

NCT07638059Not ApplicableNot Yet Recruiting

The Influence of Obesity and Insulin Sensitivity on Reward Processing and Decision Making

NCT07633704Not ApplicableCompletedPrimary

Protective Effect of Exercise on Acute High-fat Overfeeding

NCT07194772Not ApplicableCompleted

Sucralose and Glucose Metabolism in Young Healthy Adults

NCT06688461Not ApplicableRecruiting

High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes

NCT04485871Not ApplicableRecruiting

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

NCT06320951Phase 2Not Yet Recruiting

VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

NCT07255807Not ApplicableNot Yet Recruiting

Defining the Human Insulin Resistance Molecular Network; SIGNATURE

NCT04430439Not ApplicableCompleted

Emotion-Diet Interactions in Pregnancy

NCT06909006Phase 3Not Yet Recruiting

Semaglutide Treatment in Type 1 Diabetes

NCT04482374Recruiting

Puberty Suppression and Cardiometabolic Health

NCT06856291Recruiting

Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

NCT04496154Not ApplicableCompleted

Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood

NCT06772857Early Phase 1Active Not RecruitingPrimary

Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients

NCT06766617Not ApplicableCompletedPrimary

Assessment of Insulin Sensitivity in Healthy Adults by a 13C-glucose Breath Test : Method Development and Validation

NCT06694012Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

NCT04182464Not ApplicableCompletedPrimary

Effects of Sucralose in Insulin Sensitivity

Scroll to load more

Research Network

Activity Timeline